ORAI3 contributes to hypoxia-inducible factor 1/2α-sensitive colon cell migration by Zhu, D. et al.
ORAI3 contributes to hypoxia-inducible factor
1/2a-sensitive colon cell migration
D. ZHU1,3, R. HE2, W. YU1, C. LI4, H. CHENG1, B. ZHU1 and J. YAN1p
1 Department of Physiology, Jining Medical University, Jining, Shandong, China
2 School of International Education, Xinxiang Medical University, Xinxiang, Henan, China
3 Department of Urology Surgery, The First People's Hospital of Shangqiu, Shangqiu, Henan, China
4 Department of Physiology, Zhengzhou University, Zhengzhou, Henan, China
Received: August 30, 2020 • Accepted: December 29, 2020
Published online: June 22, 2021
© 2020 Akademiai Kiado, Budapest
ABSTRACT
Background: Hypoxia is a pivotal initiator of tumor angiogenesis and growth through the stabilization of
hypoxia-inducible factors (HIFs). This study set out to examine the involvement of HIF-1a and HIF-2a in
colon cancer and ascertained whether ORAI3 was involved in the pathway.Materials and methods: Patients
and murine models as well as human colorectal adenocarcinoma tumor (CW2) cells were included to
examine the levels of ORAI1/3 and HIF-1/2a levels. Calcium imaging was utilized to ascertain the activity
of calcium channel. Scratch assay was used to assess the migration capacity of the cells. Results: Tumors
from murine colon cancer xenograft models and patients with colon cancer displayed high ORAI1/3 and
HIF-1/2a levels. Hypoxia treatment, mimicking the tumor microenvironment in vitro, increased ORAI1/3
and HIF-1/2a expression as well as store-operated Ca2þ entry (SOCE). Of note is that HIF-1/2a silencing
decreased SOCE, and HIF-1/2a overexpression facilitated SOCE. Furthermore, ORAI3 rather than ORAI1
expression was inhibited by HIF-1/2a silencing while increased by ML228. Luciferase assay also confirmed
that ORAI3 was elevated in the presence of ML228, indicating the linkage between HIF-1/2a and ORAI3.
Additionally, colony-forming potential and cell migration capacity were decreased in siHIF-1a and siHIF-
2a as well as siORAI3 cells, and the facilitating effect of ML228 on cell migration and colony-forming
potential was also decreased in siORAI3 CW-2 cells, which points out the importance of ORAI3 in HIF1/2a
pathway. Conclusion: Our findings allow to conclude that both HIF-1a and HIF-2a facilitate ORAI3
expression, hence enhancing colon cancer progression.
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INTRODUCTION
Solid tumor tissue is often hypoxic due to the limited supporting capacity of normal tissue
vasculature. Activation of hypoxia-inducible factors (HIFs) is the major pathway adopted by
hypoxic cells in the tumor microenvironment, and is of great importance for tumor angiogenesis
as well as growth [1]. HIFs are heterodimeric basic helix-loop-helix (bHLH)/Per-ARNT-Sim
(PAS) transcription factor complexes, and are composed of an oxygen-liable a-subunit (HIFa)
and a constitutively expressed b-subunit [2]. Stabilization of HIFa in response to hypoxia ac-
tivates HIF complexes and results in the rapid accumulation of proteins needed for oxygen
delivery [3]. HIF-1a and HIF-2a, the main drivers of the cellular response to low oxygen, are
involved in the poor outcome of tumors [4–6].
Intracellular calcium (Ca2þ) concentration contributes to the orchestration of many cellular
functions, including cell cycle progression and cell migration that are essential for cancer for-
mation [7–9]. Store-operated Ca2þ channel (SOCC) is the primary pathway for Ca2þ influx in
cancer cells, which is mainly activated by Ca2þ release from intracellular stores and triggered
physiologically through stimulation of a wide variety of surface receptors. SOCC is accomplished
by the pore-forming Ca2þ channel subunits calcium release-activated calcium channel protein
(ORAI) 1, ORAI2, and ORAI3 [9–11] as well as their regulators, stromal interaction molecule
(STIM) 1 and STIM2 [12, 13]. The reduction of store-operated Ca2þ entry (SOCE) inhibits the
metastasis of breast, esophageal, cervical and prostate tumors [14–18]. As the major components
of SOCC, ORAI1 and STIM1 are closely related to poor clinical outcomes in gastric and
colorectal cancers [19, 20]. Meanwhile, emerging evidence shows that ORAI3 is also involved in
carcinoma, including breast and prostate as well as lung cancer [21–23]. Noteworthy is that
SOCC in estrogen receptor a-expressing (ERaþ) breast cancer cells is mediated by ORAI3
instead of the canonical ORAI1 pathway [24]. Besides, Azimi et al. reported the elevated ORAI3
level in breast cancer cells under hypoxia and confirmed the involvement of HIF-1a [25],
underlying the merge of HIF-1a and ORAI3 in carcinogenesis. HIF-1a is the best known and
most widely described isoform, whereas the expression of HIF-2a is restricted to the lung, heart
and gut [26]. Yet for the overexpression of HIF-2a in colorectal cancer [27, 28] the functions
and related mechanism of HIF-2a in cancer remain elusive. Here, we established the colon
cancer model and used molecular approaches to address the relationship between HIF1/2a and
ORAI3 in the context of colon carcinogenesis.
MATERIALS AND METHODS
Ethics statement
The protocols and the use of animals were approved by Jining Medical University and Xinxiang
Medical University Animal Care and Use Committee.
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Patients’ samples
Tumor samples from 32 patients with colon cancer were collected between September 2019 and
March 2020 at the First People’s Hospital of Shangqiu (China). All patients gave written
informed consent. Written informed consent was obtained from all patients who participated in
the study, and the study was approved by the First People’s Hospital of Shangqiu Ethics Review
Board.
Cell culture and drugs
Experiments were performed in CW-2 (Procell, China) carcinoma cells grown in DMEM media
(Sigma, USA), containing 10% fetal calf serum (Gibco) and 1% antibiotic/antimycotic solution. For
hypoxia treatment, cells were subjected to hypoxia (1% O2) for 12 h in a humidified hypoxia chamber
(Stem Cell Technology, USA). Control cells were cultured in normoxic condition (5% CO2).
ML228 (MedChemExpress), a potent HIF pathway activator[29] and was administered at 5
mM.
The Orai3 knockdown plasmid was constructed using a lentivirus/GV248 plasmid (hU6-
MCS-Ubiquitin-EGFP-IRES-puromycin) (Byotime) with an insert of shRNA (CCGGTGTG-
GCCTTTGCCCTGCATTTCTCGAGAAATGCAGGGCAAAGGCCACATTTTTTG) targeting
human Orai3. The shRNA virus and the negative control virus were packaged into HEK293T
cells, and the titers were evaluated. The viruses were used to infect CW-2 cells. The stable
transfected cells were selected using puromycin (10 mg/mL).
For silencing, 1 3 105 cells were seeded 24 h before the experiment in antibiotic-free me-
dium. Cells were transfected with 5 mL/1000 mL ON-TARGETplus Human Orai3 siRNA (5 mM,
Thermo Fisher Scientific) and ON-TARGETplus Human Hif-1/2a siRNA (5 mM) as well as
ON-TARGETplus Non-targeting siRNA (5 mM) using the cationic lipid DharmaFECT 1
transfection reagent (0.5 mL/1000 mL) according to the manufacturer’s protocol. Cells were
collected 24 h after transfection. To confirm the silencing efficiency, transcript levels were
quantified by Western blotting and RT-PCR (Figs 1 and 3).
For overexpression, a Hif-1/2a overexpression plasmid was constructed by inserting human
Hif-1/2a cDNA into a lentivirus/GV358 plasmid (GeneChem). The expression virus and lentivirus/
GV358 were packaged into HEK293T cells, and the viruses were used to infect CW-2 cells.
Western blotting
Protein was separated by SDS-PAGE, thereafter transferred to PVDF membrane and blocked in
5% non-fat milk at room temperature for 1 h. Membranes were probed overnight at 4 8C with
polyclonal rabbit anti-ORAI1 (1:1000, Abcam), anti-ORAI2 (1:1000, Abcam), anti-ORAI3
(1:1000, Abcam), HIF-2a (1:1000, cell signaling), HIF-1a (1:1000, cell signaling). After incu-
bation with horseradish peroxidase-conjugated anti-rabbit secondary antibody (1:2000, Sigma)
for 1 h at room temperature, the bands were visualized with enhanced chemiluminescence
reagents (Sigma). Membranes were probed with GAPDH antibody as the loading control.
Real-time PCR
Total RNA was extracted from cells in TriFast (Peqlab). After DNAse digestion, reverse tran-
scription of total RNA was performed using Transcriptor High Fidelity cDNA Synthesis Kit
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(Roche). Real-time polymerase chain reactions (RT-PCR) of the respective genes were set up in a
total volume of 20 mL using 40 ng of cDNA, 500 nM forward and reverse primer and 2 3
GoTaq qPCR Master Mix (Promega). Cycling conditions were as follows: 95 8C for 5 min,
followed by 40 cycles of 58 8C for 30 s and 72 8C for 20 s.
The following primers were used (5ʹ > 3ʹ):
For Orai1:
Fw: GGTAGCGATGGTGGAAGTC; Rev: GACCGAGTTGAGGTTGTGG
For Orai2:
Fw CGTCTAACCACCATTCGG; Rev: CAAACAGATGCACGGCTA
For Orai3:
Fw: GCGGCTACCTGGACCTTA; Rev: TTGCTCACGGCTTCAATAT
For Hif-1a:
Fw: CAGCCAGCAAGTCCTTCTGA; Rev: GGAGGGCTTGGAGAATTGCT
For Hif-2a:
Fw: TTGCTTATTGGTGTTGCTGCC; Rev: CAACATTCCCACACACTGCAG
For Tbp (TATA-box binding protein):
Fw: ACTCCTGCCACACCAGCC; Rev: GGTCAAGTTTACAGCCAAGATTCA
The specificity of PCR products was confirmed by analysis of a melting curve. Real-time PCR
amplifications were performed on a CFX96 Real-Time System (Bio-Rad). Tbp was amplified to
standardize the amount of sample RNA. Relative quantification of gene expression was achieved
using the ΔCT method.
Luciferase reporter assay






Then CW-2 cells were then co-transfected with the pGL3-ORAI3-30-UTR and Renilla
plasmid using Lipofectamine 2000 (Invitrogen) in the presence of ML228. 48 h after trans-
fection, cell lysates were used for detecting firefly luciferase and Renilla luciferase activities using
the luciferase reporter gene assay kit (Promega). The ratio of firefly to Renilla luciferase activity
was used to express luciferase activities.
Ca2þ measurements
Cells were loaded with Fura-2/AM (1 mM, Invitrogen) for 15 min at 37 8C. Cells were excited
alternatively at 340 nm and 380 nm. Emitted fluorescence intensity was recorded at 505 nm.
Data were acquired using Metafluor. Cytosolic Ca2þ concentration was estimated from the 340
nm/380 nm ratio. SOCE was determined by extracellular Ca2þ removal and subsequent Ca2þ re-
addition in the presence of sarco-/endoplasmic reticulum Ca2þ/ATPase (SERCA) inhibitor
thapsigargin (1 mM, Invitrogen). The slope (delta ratio/s) represents the velocity of elevated
[Ca2þ]i and peak (delta ratio) represents the amplitude of elevated [Ca
2þ]i.
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Scratch assay
CW-2 cells were seeded in a 6-well plate (NEST Biotechnology) and incubated until they
reached confluent monolayer. The monolayer was wounded using a 200 mL pipette tip. The
movement of cells in the scratched area is photographically monitored at 0 and 24 h after
treatment. The percentage of scratch coverage of cells was measured.
Colony formation assay
Single-cell suspension (105) of CW-2 cells was seeded into 6-well plates under hypoxia. Then
cells were allowed to grow for 10 days under hypoxia. To visualize colonies, cells were fixed with
methanol and stained with 0.5% crystal violet. Colonies with ≥50 cells were manually quantified.
Colony formation rate ¼ ðcolonies numbersÞ=ðnumber of planted cellsÞ 100%
Murine colon cancer xenograft models
Thymic NCr-nu/nu mice, 6 weeks of age with an average body weight of 20 g, were obtained
from Beijing Vital River Laboratory Animal Technology Company. CW-2 cells (107 cells) were
implanted in the left flank of each nude mouse. Sodium chloride was used as vehicle controls.
Tumor sizes were measured twice weekly after initial detection. Tumor volume was calculated
using the formula: tumor volume (mm3) 5 length 3 width 3 height 3 3.14/6. On day 21, the
animals were sacrificed, and the subcutaneous tumors were harvested.
Stable Orai3 knockdown cells (shRNA-Orai3) and vector control cells (NC) were injected
into the flanks of nude mice. Mice were sacrificed in 25 days, and cancer formation was
examined.
Statistics
Data are provided as means ± SEM, n represents the number of independent experiments. All
data were tested for significance using unpaired Student t-test. Only results with p<0.05 were
considered statistically significant.
RESULTS
High expression of ORAI1/3 and HIF1/2a in colon cancer
By establishing colon cancer xenograft models, we confirmed the enhanced expression of
ORAI1/3 and HIF-1/2a in the tumor tissue as compared with the healthy colon tissues (Fig. 1A
and B). Consistently, tumors obtained from patients with colon cancer showed higher levels of
ORAI1/3 and HIF-1/2a than the adjacent colon tissues (Fig. 1C and D).
Elevated ORAI1/3 and HIF-1/2a as well as SOCC under hypoxia
To mimic the hypoxic tumor microenvironment, we checked the protein levels of ORAI1/3 and
HIF-1/2a in response to prolonged hypoxia in CW-2 cells. ORAI1/3 and HIF-1/2a expression was
significantly exacerbated under hypoxia in CW-2 cells (Fig. 1E, F). Moreover, hypoxia also
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Fig. 1. Upregulation of ORAI1/3 and HIF-1/2a in colon cancer.
(A) Original western blot showing the ORAI1/2/3 and HIF-1/2a proteins in the colon tumors and healthy
colon tissues from xenograft models. (B) Arithmetic means ± SEM (n 5 32) showing the ORAI1/2/3 and
HIF-1/2a proteins in the colon tumors and healthy colon tissues from xenograft models. (C) Original
western blot showing the ORAI1/2/3 and HIF-1/2a proteins in the colon tumors from patients with colon
cancer and adjacent tissue. (D) Arithmetic means ± SEM (n 5 32) showing the ORAI1/2/3 and HIF-1/2a
proteins in the colon tumors from patients with colon cancer and adjacent tissue. (E) Original western blot
(n 5 4) showing the protein levels of ORAI1/3, and HIF-1/2a in CW-2 cells after hypoxia treatment for 12
h. (F) Arithmetic means ± SEM (n 5 4) showing the protein levels of ORAI1, ORAI3, and HIF-1/2a in
CW-2 cells after hypoxia treatment for 12 h. (G) Arithmetic means (± SEM, n 5 7) of fura-2 fluorescence-
ratio before and following extracellular Ca2þ removal and addition of thapsigargin (1 mM), and re-addition
of extracellular Ca2þ in CW-2 cells after hypoxia treatment for 12 h. (H) Arithmetic means (± SEM, n5 7)
of fura-2 fluorescence-ratio before and following extracellular Ca2þ removal and addition of thapsigargin
(1 mM), and re-addition of extracellular Ca2þ in siOrai1 as well as siNEG CW-2 cells. (I) Arithmetic means
(±SEM, n5 7) of fura-2 fluorescence-ratio before and following extracellular Ca2þ removal and addition of
thapsigargin (1 mM), and re-addition of extracellular Ca2þ in siOrai3 as well as siNEG CW-2 cells.
pppP < 0.001 indicates a statistically significant difference
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Fig. 2. Reduced SOCE activity in siHif-1/2a cells.
(A) Arithmetic means (± SEM, n 5 6) of fura-2 fluorescence-ratio following extracellular Ca2þ removal
and addition of thapsigargin (1 mM), and re-addition of extracellular Ca2þ in siNEG cells and siHif-1a CW-
2 cells. (B) Arithmetic means (± SEM, n 5 6) of fura-2 following extracellular Ca2þ removal and addition
of thapsigargin (1 mM), and re-addition of extracellular Ca2þ in control and OE-Hif-1a CW-2 cells. (C)
Arithmetic means (± SEM, n 5 6) of fura-2 following extracellular Ca2þ removal and addition of thap-
sigargin (1 mM), and re-addition of extracellular Ca2þ in siNEG cells and siHif-2a CW-2 cells. (D)
Arithmetic means (± SEM, n 5 6) of fura-2 following extracellular Ca2þ removal and addition of thap-
sigargin (1 mM), and re-addition of extracellular Ca2þ in control and OE-Hif-2a CW-2 cells.
ppppP < 0.001 indicate a statistically significant difference
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Fig. 3. HIF-1/2a silencing specifically decreased ORAI3.
(A) Original western blot and arithmetic means ± SEM (n 5 5) showing ORAI1, ORAI2, and ORAI3
protein expression in siHif-1a CW-2 cells. (B) Original western blot and arithmetic means ± SEM (n 5 5)
showing ORAI1, ORAI2, and ORAI3 protein expression in siHif-2a CW-2 cells. (C) Original western blot
and arithmetic means ± SEM (n5 5) showing ORAI3 protein expression in the presence of ML228 (5 mM)
in CW-2 cells. (D) Arithmetic means ± SEM (n 5 4) of the trans-activity of ORAI3 in the presence of
ML228 (5 mM) in CW-2 cells.
pppP < 0.001 indicates a statistically significant difference
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Fig. 4. HIF-1/2a-enhanced carcinoma phenotypes are ORAI3 sensitive.
(A) Arithmetic means ± SEM (n 5 5) of colony formation by siHif-1a CW-2 cells. (B) Original images
and arithmetic means ± SEM (n 5 5) of migration of siHif-1a CW-2 cells in scratch assay. (C) Arithmetic
means ± SEM (n 5 5) of colony formation by siHIF-2a CW-2 cells. (D) Original images and arithmetic
means ± SEM (n 5 5) of migration of siHif-2a CW-2 cells in scratch assay. (E) Arithmetic means ± SEM
(n 5 5) of colony formation by siNEG and siOrai3 cells. (F) Original images and arithmetic means ± SEM
(n 5 5) of the migration in siNEG and siOrai3 cells. (G) Arithmetic means ± SEM (n 5 5) of colony
formation by siNEG and siOrai3 cells in the presence of ML228 (5 mM) for 12 h. (H) Original images and
arithmetic means ± SEM (n 5 5) of the migration in siOrai3 cells in the presence of ML228 (5 mM) for 12
h. (I) Arithmetic means ± SEM (n 5 12) of tumor volumes in shNEG and shOrai3 nude mice.
pppP < 0.001 indicates a statistically significant difference
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considerably increased SOCE, including Ca2þ released from store and Ca2þ entry (Fig. 1G).
Additionally, both ORAI1 and ORAI3 silencing significantly suppressed Ca2þ entry in CW-2 cells
(Fig. 1H and I), whereas ORAI2 knock-down had no observable effect on SOCE (data not shown).
SOCC activity is HIF-1/2a dependent in CW-2 cells
To examine the specific role of each HIF homolog in SOCE, we manipulated the expression of
HIF-1a and HIF-2a in CW-2 cells. SOCE activity was decreased in siHIF-1a cells (Fig. 2A). The
peak and slope representing SOCE were significantly lower in siHIF-1a cells than those in siNEG
cells. Meanwhile, HIF-1a was overexpressed (termed over-expression cells, OE-HIF-1a, and
virus-negative control, NC). As illustrated in Fig. 2B, SOCE activity was higher in OE-HIF-1a
cells than in NC cells. Similarly, siHIF-2a cells showed lower SOCC activity than siNEG cells
(Fig. 2C), whereas OE-HIF-2a cells displayed higher SOCC activity than NC cells (Fig. 2D). The
findings above indicate that both HIF-1a and HIF-2a contribute to SOCE.
To identify the components of SOCE regulated by HIF-1/2a, ORAI1/2/3 expression was
quantified by western blot. ORAI3 expression was significantly decreased in siHIF-1/2a cells
(Fig. 3A and B), and enhanced by ML228 treatment (Fig. 3C). HIF-1a deletion did not affect the
levels of ORAI1 and ORAI2 (Fig. 2). Moreover, we utilized a pGL3-ORAI3-30-UTR luciferase
reporter vector to check whether ORAI3 transcription was regulated by HIFs. As shown in
Fig. 3D, ML228 treatment dramatically increased the transcription of ORAI3, which reflected
that HIF-1/2a facilitated ORAI3 at the transcriptional level.
Role of HIF-1/2a in colon cancer is ORAI3-dependent
siHIF-1a and siHIF-2a deficiency inhibited colony-forming potential and cell migration capacity
(Fig. 4A–D). Moreover, ML228 enhanced colony-forming potential and migration capacity, and
these effects could be abolished by ORAI3 silencing (Fig. 4E and F). Ultimately, ORAI3 knockdown
markedly suppressed the tumor volume of colon cancer xenograft models (Fig. 4G and I).
DISCUSSION
We explored the role of HIF-1/2a in colon cancer and demonstrated the involvement of
ORAI3 in the process. It is generally accepted that SOCE, whose inhibition reduces tumor size
in breast cancer as well as esophageal cancer [15] is related to carcinogenesis. STIM1 and
ORAI1, the major components of SOCE are overexpressed in a wide variety of cancers [15, 30–
32]. Yet for a long time there has been a debate as to whether or not SOCE can be modulated
by a pathway involving ORAI3. We confirmed that both ORAI1 and ORAI3 deficiency
decreased SOCE in CW-2 cells. There is a growing appreciation for the involvement of ORAI3
rather than ORAI1 in carcinogenesis [33, 34]. Herein, we observed the enhanced expression of
ORAI1 and ORAI3 in colon cancer patients and mice models, and found that ORAI3 defi-
ciency led to a significant reduction of the colon tumor volume in vivo and the migration
capacity in vitro.
As for the modulation of ORAI3, Motiani et al. proposed that ERa silencing significantly re-
duces ORAI3 level by 42% in breast cancer [21], indicating the regulatory role of ERa in ORAI3
and reflecting the existence of additional Orai3 regulatory mechanisms. Azimi et al. clearly reported
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increased ORAI3 involving the HIF-1a pathway in breast cancer cells [25]. We found that that
HIF-2a and HIF-1a are equally important for ORAI3 expression in colon cancer.
HIFs are intrinsic markers of tumor hypoxia and are pivotal for tumor angiogenesis and
growth. Enhanced expression of HIF-1/2a is associated with cancer progression including
colorectal cancer [27, 28]. Zhu et al. suggest that HIF-1a directly controls Stim1 tran-
scription and contributes to SOCE under hypoxia [35]. Meanwhile, as described by Azimi
(2019), HIF-1a increases the ORAI3 level in breast cancer cells [25], which is consistent
with our results in CW-2 cells. Moreover, the luciferase assay identified the linkage between
ORAI3 and HIF-1/2a. Nevertheless, Wang et al. found that exposure to chronic hypoxia
enhanced the levels of both ORAI1 and ORAI2 but not ORAI3 in pulmonary arterial
smooth muscle cells (PASMs) [36]. This discrepancy might be attributed to the excitable cell
type of PASMs and the limited expression of ORAI3. PASMs belong to excitable cells that
are mainly triggered by L-type calcium channel, and ORAI3 preferentially exists in tumor
cells.
There has been a long-term interest in distinguishing the roles of HIF-1a and HIF-2a. HIF-
1a and HIF-2a share very similar characteristics and regulate many common genes, whereas the
expression of HIF-2a is restricted to the lung, heart and gut [26]. HIF-2a preferentially regulates
genes important for tumor growth and cell cycle progression [37]. According to Maranchie
(2002), HIF-2a (and not HIF-1a) promotes tumor growth in a renal carcinoma xenograft model
[38]. We found that the migration and colony formation of CW-2 cells were inhibited by both
HIF-1a and HIF-2a silencing. Notwithstanding its limitations, such data provide an impetus for
considering the HIFs-ORAI3 axis as a potential target for colon cancer therapy.
In this study, we provide evidence supporting the notion that both HIF-1a and HIF-2a
contribute to the migration of colon cancer and facilitate tumor formation by specifically
recruiting ORAI3, highlighting a critical relationship of HIF-1/2a and ORAI3.
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